The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial
出版年份 2013 全文链接
标题
The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial
作者
关键词
-
出版物
European Journal of Preventive Cardiology
Volume 21, Issue 3, Pages 299-309
出版商
SAGE Publications
发表日期
2013-11-05
DOI
10.1177/2047487313510678
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease
- (2013) Regina Kunz et al. ANNALS OF INTERNAL MEDICINE
- Clinical Significance of Incident Hypokalemia and Hyperkalemia in Treated Hypertensive Patients in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
- (2012) Michael H. Alderman et al. HYPERTENSION
- Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy
- (2012) Sara S. Roscioni et al. Nature Reviews Nephrology
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction
- (2011) Scott D. Solomon et al. EUROPEAN HEART JOURNAL
- An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function
- (2011) Frank A. Holtkamp et al. KIDNEY INTERNATIONAL
- Serum Potassium and Outcomes in CKD: Insights from the RRI-CKD Cohort Study
- (2010) S. Korgaonkar et al. Clinical Journal of the American Society of Nephrology
- Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
- (2010) Y. Miao et al. DIABETOLOGIA
- Dual RAS Therapy Not on Target, but Fully Alive
- (2010) H.J. Lambers Heerspink et al. NEPHRON CLINICAL PRACTICE
- Risk of Hyperkalemia in Nondiabetic Patients With Chronic Kidney Disease Receiving Antihypertensive TherapyHyperkalemia in CKD Adults Using Antihypertensives
- (2009) Joy M. Weinberg ARCHIVES OF INTERNAL MEDICINE
- The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
- (2009) Lisa M. Einhorn et al. ARCHIVES OF INTERNAL MEDICINE
- Mechanisms of Impaired Potassium Handling With Dual Renin-Angiotensin-Aldosterone Blockade in Chronic Kidney Disease
- (2009) Richard A. Preston et al. HYPERTENSION
- Mechanisms in Hyperkalemic Renal Tubular Acidosis
- (2009) F. E. Karet JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease
- (2009) M. Frimodt-Moller et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
- (2008) Johannes FE Mann et al. LANCET
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started